Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective
出版年份 2014 全文链接
标题
Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective
作者
关键词
Narrow therapeutic index drugs (NTID), Tyrosine kinase inhibitors (TKI), Orphan drug status
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 33, Issue 1, Pages 15
出版商
Springer Nature
发表日期
2014-02-07
DOI
10.1186/1756-9966-33-15
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase I Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
- (2013) S. I. Shibata et al. CLINICAL CANCER RESEARCH
- Role of Epidermal Growth Factor Receptor Inhibitors in Epidermal Growth Factor Receptor Wild-Type Non–Small-Cell Lung Cancer
- (2013) Scott A. Laurie et al. JOURNAL OF CLINICAL ONCOLOGY
- Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia
- (2012) Francis J. Giles et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors
- (2012) Jeffrey R. Infante et al. INVESTIGATIONAL NEW DRUGS
- Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer
- (2012) Samuel Murray et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
- (2012) Fen Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects
- (2011) Richat Abbas et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors
- (2011) A. I. Daud et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Finding Study of Pazopanib in Hepatocellular Carcinoma: Evaluation of Early Efficacy, Pharmacokinetics, and Pharmacodynamics
- (2011) T. Yau et al. CLINICAL CANCER RESEARCH
- Platinum resistance in breast and ovarian cancer cell lines
- (2011) Niels Eckstein JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
- (2011) Carlo Gambacorti-Passerini et al. JNCI-Journal of the National Cancer Institute
- A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies
- (2009) H. A. Burris et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
- (2009) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- To kill a tumor cell: the potential of proapoptotic receptor agonists
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL INVESTIGATION
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
- (2008) A. Vultur et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started